CONTACT INFORMATIONBIOGRAPHYCREDENTIALSAWARDSPUBLICATIONSDavid Maxwell Kleinman, M.D., M.B.A.Contact InformationPhone NumbersAppointment: (585) 273-3937Office: (585) 273-3937Fax: (585) 276-1189A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentAccepting New PatientsLocations210 Crittenden Blvd, Floor 3Strong Flaum Eye InstituteRochester, NY 14642-0002Ophthalmology: (585) 273-3937Faculty AppointmentsAssociate Professor (Part-Time) - Department of Ophthalmology (SMD) Patient Care SettingOphthalmologyBiographyDavid M. Kleinman, MD, MBA, FACS is a board certified ophthalmologist with fellowship training in vitreoretinal surgery. Dr. Kleinman received his medical degree with honors and completed a subsequent residency in ophthalmology at the University of Colorado School of Medicine. He then received additional training through a fellowship in vitreoretinal surgery at the University of Toronto School of Medicine. Dr. Kleinman is the former Chief of Ophthalmology at Denver Health Medical Center in Denver, Colorado where he also served as Director of Ophthalmic Trauma Services and Assistant Professor of Ophthalmology at the Rocky Mountain Lions Eye Institute. Besides attending to his clinical practice at the University of Rochester Eye Institute, Dr. Kleinman is President and Co-founder of Eyeon Therapeutics, Inc. a start-up firm developing new treatments for eye diseases. He also serves as a consultant to both large and small ophthalmic pharmaceutical and device companies nationally. Dr. Kleinman's research involves the pharmaceutical treatment of diabetic retinopathy and age related macular degeneration. He has made numerous contributions to clinical and research publications in national and international journals of ophthalmology, and has made presentations throughout the world. In addition, he participated as a surgeon for the Himalayan Cataract Project and served as a staff ophthalmologist for Project ORBIS International, Inc. National Clinical Trials involve VEGF trap treatment for age related macular degeneration and Age related eye disease study 2. Retina research trials involve Adaptive Optics Imaging of Inherited Macular Diseases.ResearchDr. Kleinman's research involves the pharmaceutical treatment of diabetic retinopathy and age related macular degeneration. He has made numerous contributions to clinical and research publications in national and international journals of ophthalmology, and has made presentations throughout the world. In addition, he participated as a surgeon for the Himalayan Cataract Project and served as a staff ophthalmologist for Project ORBIS International, Inc. National Clinical Trials involve VEGF trap treatment for age related macular degeneration and Age related eye disease study 2. Retina research trials involve Adaptive Optics Imaging of Inherited Macular Diseases.CredentialsSpecialtiesOphthalmology - American Board of OphthalmologyEducation1993MD | University of Colorado School of MedicinePost-doctoral Training & Residency7/01/99 - 6/30/00Fellowship in at University of Toronto7/01/94 - 6/30/97Residency in Ophthalmology at University of Colorado School of Medicine6/24/93 - 6/23/94Internship in Internal Medicine at University of Washington Medical CenterVIEW ALL expand_moreAwards2006Community Faculty of the Year. Rochester Eye Institute, University of Rochester School of Medicine. Rochester, New York.2005Rochester Regional Business Plan Contest Winner, Eyeon Therapeutics, Inc2004William L. Vick Award in Entrepreneurship, William E. Simon Graduate School of Business Administration, University of Rochester,2003 - 2004Deans List; William E. Simon Graduate School of Business Administration, University of Rochester2002 - 2004Deans Scholar; William E. Simon Graduate School of Business Administration, University of Rochester. Full tuition scholarship for MBA degree:2001American Medical Association Physicians Recognition Award in Continuing Medical Education;1996American Medical Association Physicians Recognition Award in Continuing Medical Education1992 - 1993Edgar and Marion Adler Scholar Award; (for academic merit and creativity in medical school)1990 - 1991Edgar and Marion Adler Scholar Award for academic merit and creativity in medical school)VIEW ALL expand_morePublicationsJournal Articles11/1/2020Ho AC, Kleinman DM, Lum FC, Heier JS, Lindstrom RL, Orr SC, Chang GC, Smith EL, Pollack JS. "Baseline Visual Acuity at Wet AMD Diagnosis Predicts Long-Term Vision Outcomes: An Analysis of the IRIS Registry." Ophthalmic surgery, lasers & imaging retina.. 2020 Nov 1; 51(11):633-639. 8/28/2020Chen A, Dang S, Chung MM, Ramchandran RS, Bessette AP, DiLoreto DA, Kleinman DM, Sridhar J, Wykoff CC, Kuriyan AE. "Quantitative Comparison of Fundus Images by Two Ultra-Wide Field Fundus Cameras." Ophthalmology retina.. 2020 Aug 28; Epub 2020 Aug 28. 7/2018Jampol LM, Glassman AR, Liu D, Aiello LP, Bressler NM, Duh EJ, Quaggin S, Wells JA, Wykoff CC, . "Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema." Ophthalmology.. 2018 Jul 0; 125(7):1054-1063. Epub 2018 Mar 07. VIEW ALL PUBLICATIONSClose WindowSchedule an appointment with David Maxwell Kleinman, M.D., M.B.A.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. David Maxwell Kleinman, M.D., M.B.A. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.